166 related articles for article (PubMed ID: 32972820)
1. Prognostic role of the recepteur d'origine nantais (RON) expression in primary high-grade osteosarcoma.
Wang SL; Weng DF; Wei HX; Huang Z; Lin RQ; Shi K; Lin JH
J Orthop Sci; 2021 Nov; 26(6):1100-1106. PubMed ID: 32972820
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
[TBL] [Abstract][Full Text] [Related]
3. The Complete Loss of Tyrosine Kinase Receptors MET and RON Is a Poor Prognostic Factor in Patients with Extrahepatic Cholangiocarcinoma.
Hayashi Y; Yamaguchi J; Kokuryo T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nagino M
Anticancer Res; 2016 Dec; 36(12):6585-6592. PubMed ID: 27919987
[TBL] [Abstract][Full Text] [Related]
4. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
[TBL] [Abstract][Full Text] [Related]
5. Pathological significance of abnormal recepteur d'origine nantais and programmed death ligand 1 expression in colorectal cancer.
Liu YZ; Han DT; Shi DR; Hong B; Qian Y; Wu ZG; Yao SH; Tang TM; Wang MH; Xu XM; Yao HP
World J Gastrointest Oncol; 2020 Nov; 12(11):1216-1236. PubMed ID: 33250957
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of RON and MET receptor coexpression in patients with colorectal cancer.
Lee CT; Chow NH; Su PF; Lin SC; Lin PC; Lee JC
Dis Colon Rectum; 2008 Aug; 51(8):1268-74. PubMed ID: 18536971
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients.
Ferrandina G; Martinelli E; Petrillo M; Prisco MG; Zucconi A; Santaguida S; Zannoni G; Scambia G; Ferlini C
Gynecol Oncol; 2008 Nov; 111(2):237-43. PubMed ID: 18718649
[TBL] [Abstract][Full Text] [Related]
8. Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer.
Kim N; Cho SB; Park YL; Park SY; Myung E; Kim SH; Yu HM; Son YA; Myung DS; Lee WS; Joo YE
Oncol Rep; 2016 Jun; 35(6):3331-40. PubMed ID: 27035413
[TBL] [Abstract][Full Text] [Related]
9. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
Thangasamy A; Rogge J; Ammanamanchi S
J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
[TBL] [Abstract][Full Text] [Related]
10. Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression.
Yang SY; Nguyen TT; Ung TT; Jung YD
Chonnam Med J; 2017 Sep; 53(3):178-186. PubMed ID: 29026705
[TBL] [Abstract][Full Text] [Related]
11. Expression of RON in colorectal cancer and its relationships with tumor cell behavior and prognosis.
Park YL; Lee GH; Kim KY; Myung E; Kim JS; Myung DS; Park KJ; Cho SB; Lee WS; Jung YD; Kim HS; Joo YE
Tumori; 2012; 98(5):652-62. PubMed ID: 23235762
[TBL] [Abstract][Full Text] [Related]
12. Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells.
Yu Q; Wang J; Li T; Guo X; Ding S; Che X; Zhu L; Peng Y; Xu X; Zou G; Zhang X
J Cell Mol Med; 2021 Feb; 25(3):1601-1612. PubMed ID: 33410267
[TBL] [Abstract][Full Text] [Related]
13. Elevated RON protein expression in endometriosis and disease-associated ovarian cancers.
Xu P; Ding S; Zhu L; Le F; Huang X; Tian Y; Zhang X
Arch Gynecol Obstet; 2017 Mar; 295(3):631-639. PubMed ID: 27888297
[TBL] [Abstract][Full Text] [Related]
14. Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.
Yoon TM; Kim SA; Park YL; Lee KH; Sung MW; Lee JK; Lim SC; Chung IJ; Joo YE
Head Neck; 2013 Aug; 35(8):1106-13. PubMed ID: 22887469
[TBL] [Abstract][Full Text] [Related]
15. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.
Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH
Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584
[TBL] [Abstract][Full Text] [Related]
16. Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer.
Yu H; Yuan J; Xiao C; Qin Y
Int J Mol Med; 2013 May; 31(5):1248-54. PubMed ID: 23483216
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract.
Compérat E; Roupret M; Chartier-Kastler E; Bitker MO; Richard F; Camparo P; Capron F; Cussenot O
J Urol; 2008 Mar; 179(3):868-72; discussion 872. PubMed ID: 18221954
[TBL] [Abstract][Full Text] [Related]
18. RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma.
Kim SA; Yoon TM; Lee DH; Park YL; Lee KH; Lim SC; Joo YE; Lee JK
Auris Nasus Larynx; 2014 Apr; 41(2):201-6. PubMed ID: 24287326
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d'Origine Nantais.
Lian S; Park JS; Xia Y; Nguyen TT; Joo YE; Kim KK; Kim HK; Jung YD
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27689991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
